News

Bain Capital-backed Heartflow valued at $2.27 billion in solid Nasdaq debut
Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO ...
GlobalData on MSN4d
HeartFlow sets sights on $300m IPO
HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...
Devdiscourse1d
Health Developments: From Saline Surplus to IPO Triumphs
An array of health-related updates includes the resolution of the U.S. saline shortage by the FDA, predictions about a missed ...
Bain Capital-backed Heartflow eyes $1.5 billion valuation in upsized US IPO
Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...
U.S. IPO Weekly Recap: Space Company Firefly Takes Off In 7 IPO Week
Seven IPOs and two SPACs debuted this week, while five small IPOs and seven SPACs submitted initial filings. Read more here.
BioWorld2d
Heartflow raises $317M, pops 66% at market open
Heartflow Inc. upped the price of shares in its IPO for a second time to $19 on Aug. 7 before opening on the Nasdaq as “HTFL” ...
Stock Movers: Trade Desk, Sweetgreen, Heartflow
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
Backed by Bain Capital, the health technology startup makes 3D models of people's hearts to help diagnose diseases. Here's ...